|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q2 FY2024
As of Jun 30, 2024
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q2 FY2023
As of Jun 30, 2023
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Prepaid expenses and other receivables | ||||||||||||||||||||
| Prepaid expenses | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Due from related parties | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||||||
| Current liabilities | ||||||||||||||||||||
| Convertible note payable, net of unamortized debt discount | ||||||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||||||
| Amount due to related party | ||||||||||||||||||||
| Related Party | ||||||||||||||||||||
| Total amount due to related party | ||||||||||||||||||||
| Accrued interests on promissory notes | ||||||||||||||||||||
| Due to related parties | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||||||
| Commitments and contingencies (note 8) | ||||||||||||||||||||
| Shareholders' equity | ||||||||||||||||||||
| Preferred stock, Series A $0.001 par value; 50,000,000 shares authorized, 3,189,600 and 3,189,600 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Common stock $0.001 par value; 7,450,000,000 shares authorized, 1,249,709,717 and 1,221,737,689 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| TOTAL SHAREHOLDERS' EQUITY | ||||||||||||||||||||
| Total stockholders’ equity (deficit) | ||||||||||||||||||||
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | ||||||||||||||||||||
Loading...
